Biocon Limited has informed the Exchange regarding a press release dated October 06, 2023, titled "Biocon Limited signs commercialization agreement with Juno Pharmaceuticals in Canada".
Biocon Limited has informed the Exchange regarding a press release dated October 06, 2023, titled "Biocon Limited signs commercialization agreement with Juno Pharmaceuticals in Canada".